ROLE OF MILK IN COGNITIVE FUNCTION AND QUALITY OF LIFE IN OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT A1 protein free milk may provide enhanced outcomes
With
Dr Emma Beckett,
Food & Nutrition Scientist, FOODiQ Global
Professor Stephen Robinson, Psychology Research
Researcher and corresponding author &
semi-retired neuroscientist, RMIT University
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Melbourne and Newcastle, NSW | September 2025
New research emphasises the role of cows’ milk, particularly A1 protein free milk, in enhancing cognitive function and quality of life for older adults with mild cognitive impairment (MCI). A multi-centre, double-blinded, randomised controlled clinical study published in *The Journal of Nutrition, Health and Aging* evaluated 88 milk-tolerant Chinese adults aged 65-75 over three months. Participants consumed either ordinary skim milk or A1 protein free skim milk, leading to improvements in various cognitive assessments.
Both types of milk showed significant enhancements in cognitive performance across multiple tests, including the Subtle Cognitive Impairment Test (SCIT), Montreal Cognitive Assessment (MoCA), and Audio Verbal Learning Test (AVLT).
While both groups reported improvements in quality of life, the A1 protein free group noted greater gains, including a 23% increase in overall quality of life scores and a 43% improvement in memory ability. Despite challenges with vitamin D levels among participants, the study highlights the importance of milk choice in promoting cognitive health, especially for the aging population, where approximately 20% of those over 65 may experience MCI.
Researcher and corresponding author of the clinical study, Professor Stephen Robinson spoke to Australian Health Journal about the findings and the need for further research to confirm these benefits across diverse populations.
Dr Emma Beckett, food and nutrition scientist at FOODiQ, says A1PF milk, as part of a balanced diet, can play a valuable role in improving the nutrition of older adults.
“This is an exciting study because it shows that a small dietary change, adding A1PF milk, may be effective for those experiencing cognitive changes. As Australia’s population continues to age, A1PF milk may offer an accessible way to support overall health and wellbeing, particularly in adults living with MCI,” said Dr Beckett.
Source: Adapted from a2 Milk Australia media release and published study
-
Investigating use of dietary supplements for osteoarthritis
Osteoarthritis is a leading cause of disability affecting over 2 million Australians, according to Australian Institute of Health and Welfare report on Chronic musculoskeletal conditions (2024) and 595 million people globally, according to BD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990–2020. It represents a significant public health burden that diminishes quality of life among ageing populations.
-
Significant funding announced for NSW biomedical researchers
The Snow Medical Research Foundation (Snow Medical) has announced a new $24 million investment in three outstanding Australian biomedical researchers through its prestigious Snow Fellowships.
These Fellows will tackle major global health challenges spanning autoimmune disease, neurological disorders, and genetic disease. Their work addresses conditions that disproportionately affect vulnerable and underserved populations, including First Nations communities, while advancing precision medicine and translational care. Collectively, their research aims to deliver safer vaccines, better diagnostics, and more equitable genomic and neurological healthcare.
-
Nuclear medicine funding a win for men with prostate cancer
Australian men with higher risk prostate cancer now have access to a nuclear medicine scan to help detect and treat metastatic disease, after it was listed on the Medical Benefits Schedule (MBS) from 1st July 2022.
In 2021 over 18,000 Australian men were diagnosed with prostate cancer, resulting in over 3,000 lives being lost – and making prostate cancer Australia’s second most common cause of cancer death in men.
Australian Health Journal spoke with AANMS President Associate Professor Sze Ting Lee and Dr Geoff Schembri on the MBS listing and the efforts to get it listed.
